Inheritance plays an important role in the determination of human plasma dopamine-β-hydroxylase (DBH) enzymatic activity. It has been demonstrated that an allele (d) for very low enzymatic plasma DBH is inherited as an autosomal recessive trait. A radioimmunoassay for human DBH was developed to test the hypothesis that the presence of this allele results in a decrease in plasma DBH protein levels. The mean immunoreactive DBH (IDBH) in blood from a randomly selected population of adolescents was 824±38 ng/ml (mean±SEM, n = 134). The correlation coefficient of enzymatic DBH with IDBH for this group of 134 adolescents was 0.84 (P < 0.001). Of these subjects, 3.7% had values of < 100 ng/ml and appeared to compose a separate subgroup analogous to the 3-4% of the population that is homozygous for the allele for low enzymatic activity. There was a significant sibling-sibling correlation of IDBH values in the 14 sibling pairs included among the 134 subjects studied (r = 0.60, P < 0.025). IDBH was also measured in blood from 56 subjects homozygous (dd) for the allele for low enzymatic DBH (enzymatic activity < 50 U/ml) and in blood of 80 first-degree relatives of homozygous probands. All but two dd subjects had IDBH levels of <100 ng/ml. Results of family studies were compatible with the autosomal recessive inheritance of an allele for IDBH levels of less than 100 ng/ml which segregates with the allele for very low enzymatic activity. Average IDBH in blood of 37 obligate heterozygotes as determined by family studies (Dd) was 599±53 ng/ml (mean ± SEM), significantly lower than the IDBH values found in a randomly selected population (P < 0.005). These results are compatible with the conclusion that the presence of the allele for low plasma enzymatic DBH results in a decrease in the quantity of DBH protein in human plasma.
Joel Dunnette, Richard Weinshilboum
Title and authors | Publication | Year |
---|---|---|
Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction
TT Nguyen, D Liu, MF Ho, AP Athreya, R Weinshilboum |
Frontiers in pharmacology | 2021 |
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
Association between dopamine beta hydroxylase rs5320 polymorphism and smoking behaviour in elderly Japanese
E Ella, N Sato, D Nishizawa, S Kageyama, H Yamada, N Kurabe, K Ishino, H Tao, F Tanioka, A Nozawa, C Renyin, K Shinmura, K Ikeda, H Sugimura |
Journal of Human Genetics | 2012 |
Laboratory Guide to the Methods in Biochemical Genetics
N Blau, M Duran, KM Gibson |
2008 | |
Clinical Utility of Monoamine Neurotransmitter Metabolite Analysis in Cerebrospinal Fluid
K Hyland |
Clinical chemistry | 2008 |
Presentation, diagnosis, and treatment of the disorders of monoamine neurotransmitter metabolism
K Hyland |
Seminars in Perinatology | 1999 |
Optimal physical performance in athletes: key roles of dopamine in a specific neurotransmitter/hormonal mechanism
C Gilbert |
Mechanisms of Ageing and Development | 1995 |
Low risk to certain diseases in aging: Role of the autonomic nervous system and calcium metabolism
C Gilbert |
Mechanisms of Ageing and Development | 1993 |
Inheritance of human plasma dopamine-β-hydroxylase thermal stability
JP Vuchetich, J Dunnette, KL Lunetta, RM Weinshilboum, RA Price, GP Vogler |
Genetic Epidemiology | 1991 |
Multiple forms of human dopamine β-hydroxylase in SH-SY5Y neuroblastoma cells
AM Oyarce, PJ Fleming |
Archives of Biochemistry and Biophysics | 1991 |
Norepinephrine clearance, chromogranin A and dopamine β hydroxylase in renal failure
MG Ziegler, B Kennedy, E Morrissey, DT O'Connor |
Kidney International | 1990 |
Explorations into the biochemistry of sensation seeking
LL Calhoon |
Personality and Individual Differences | 1988 |
Segregation and linkage analyses of dopamine-β-hydroxylase activity in a six-generation pedigree
A Asamoah, AF Wilson, RC Elston, E Dalferes, GS Berenson, JM Opitz, JF Reynolds |
American Journal of Medical Genetics | 1987 |
CONGENITAL DOPAMINE-BETA-HYDROXYLASE DEFICIENCY
AJ Veld, P Moleman, F Boomsma, MA Schalekamp |
The Lancet | 1987 |
Serum dopamine β-hydroxylase activity in non-human primates: phylogenetic and genetic implications
JH Dunnette, RM Weinshilboum |
Comparative Biochemistry and Physiology Part C: Comparative Pharmacology | 1983 |
Family studies of plasma dopamine-beta-hydroxylase thermal stability
J Dunnette, R Weinshilboum |
The American Journal of Human Genetics | 1982 |
Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity
LR Goldin, ES Gershon, CR Lake, DL Murphy, M McGinniss, RS Sparkes |
The American Journal of Human Genetics | 1982 |
Changes in serum dopamine-beta-hydroxylase activity during cold pressor test in subjects with high and low basal activity of this enzyme
L Laurian, Z Oberman, E Kisch, A Fitermann |
Journal of Neural Transmission | 1982 |
Human plasma dopamine-β-hydroxylase: Oxygen and thermal stability
J Dunnette, R Weinshilboum |
Experientia | 1981 |
Amphetamine psychosis and schizophrenia: A dual model
L Kokkinidis, H Anisman |
Neuroscience & Biobehavioral Reviews | 1981 |
Catecholamines: Basic and Clinical Frontiers
EH LaBrosse |
Catecholamines: Basic and Clinical Frontiers | 1979 |
Lack of correlation between serum dopamine-beta-hydroxylase activity and blood pressure in middle-aged men
JK Huttunen, J Pispa, T Kumlin, S Mattila, V Naukkarinen, T Miettinen |
Hypertension | 1979 |
Human Genetic Variation in Response to Medical and Environmental Agents: Pharmacogenetics and Ecogenetics
F Vogel, W Buselmaier, W Reichert, G Kellermann, P Berg |
1978 |